IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.54%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$217M
AUM Growth
+$217M
(+1.5%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
41.84%
Holding
98
New
28
Increased
15
Reduced
17
Closed
18
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$11M |
| 2 |
Elevance Health
ELV
|
$9.19M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.84M |
| 4 |
Gilead Sciences
GILD
|
$4.17M |
| 5 |
Illumina
ILMN
|
$3.51M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$15.4M |
| 2 |
Cigna
CI
|
$13.7M |
| 3 |
Medtronic
MDT
|
$7.5M |
| 4 |
Baxter International
BAX
|
$7.01M |
| 5 |
Eli Lilly
LLY
|
$5.4M |
Sector Composition
| 1 | Healthcare | 88.35% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $12.3M | 5.02% |
125,000
-50,000
| -29% | -$4.93M |
|
2
Zimmer Biomet
ZBH
$21B
| $12M | 4.9% |
100,000
+15,000
| +18% | +$1.81M |
|
|
3
Gilead Sciences
GILD
$140B
| $11.3M | 4.58% |
135,000
+50,000
| +59% | +$4.17M |
|
|
SHPG
4
DELISTED
Shire pic
SHPG
| $11M | 4.49% |
+60,000
| New | +$11M |
|
|
5
Elevance Health
ELV
$71.8B
| $9.19M | 3.74% |
+70,000
| New | +$9.19M |
|
|
OMED
6
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $7.78M | 3.17% |
632,200
+165,175
| +35% | +$2.03M |
|
7
Merck
MRK
$210B
| $7.2M | 2.93% |
125,000
-25,000
| -17% | -$1.44M |
|
8
Pfizer
PFE
$141B
| $7.04M | 2.86% |
200,000
| – | – |
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $6.85M | 2.79% |
140,000
+20,000
| +17% | +$978K |
|
|
10
Baxter International
BAX
$12.7B
| $6.11M | 2.48% |
135,000
-155,000
| -53% | -$7.01M |
|
|
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
| $5.97M | 2.43% |
100,000
| – | – |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.84M | 2.37% |
+50,000
| New | +$5.84M |
|
13
Biogen
BIIB
$19.4B
| $5.44M | 2.21% |
22,500
-7,500
| -25% | -$1.81M |
|
14
Amgen
AMGN
$155B
| $5.33M | 2.17% |
35,000
| – | – |
|
|
GBT
15
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.98M | 2.02% |
300,000
+50,000
| +20% | +$830K |
|
16
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.58M | 1.86% |
225,000
-50,000
| -18% | -$1.02M |
|
|
DERM
17
DELISTED
Dermira, Inc.
DERM
| $4.39M | 1.79% |
150,000
+75,000
| +100% | +$2.19M |
|
18
Tenet Healthcare
THC
$16.3B
| $4.15M | 1.69% |
150,000
-25,000
| -14% | -$691K |
|
19
Glaukos
GKOS
$5.5B
| $3.94M | 1.6% |
135,000
+10,000
| +8% | +$292K |
|
20
HCA Healthcare
HCA
$94.5B
| $3.85M | 1.57% |
50,000
-50,000
| -50% | -$3.85M |
|
|
MZOR
21
DELISTED
Mazor Robotics Ltd.
MZOR
| $3.6M | 1.46% |
200,000
+75,000
| +60% | +$1.35M |
|
|
22
Illumina
ILMN
$15.8B
| $3.51M | 1.43% |
+25,000
| New | +$3.51M |
|
|
MDRX
23
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.18M | 1.29% |
250,000
| – | – |
|
|
ONCE
24
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.07M | 1.25% |
+60,000
| New | +$3.07M |
|
25
Exelixis
EXEL
$10.1B
| $2.73M | 1.11% |
350,000
+200,000
| +133% | +$1.56M |
|